SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

ISHITA DRUGS & INDUSTRIES

BSE: 524400 30 Sep 2025
Healthcare
₹ 81.4
Ishita Drugs & Industries Ltd. specializes in Pharmaceuticals within the Healthcare sector.

ISHITA DRUGS & INDUSTRIES - Share Price & Details

Market Cap
₹24.4
High /Low
99.6 / 62.4
Stock P/E
23.9
Book Value
₹36.1
Dividend Yield
0.0
ROCE
9.91
ROE
₹8.4
Face Value
10.0
PEG Ratio
8.42
EVEBITDA
₹15.2
Debt
3.90
CMP / FCF
-15.4
Debt to equity
₹0.36
NP Ann
0.87
High price all time
105.0
Piotroski score
₹3.0
Graham Number
52.6
No. Eq. Shares
0.3
Net CF
₹0.02
Net profit
1.02
Price to book value
2.26
Interest Coverage
₹17.8
Low price all time
4.91
Industry PE
33.0
Reserves
₹7.80
Free Cash Flow
₹-3.82

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
ISHITA DRUGS & INDUSTRIES LTD.NANANANA24.423.9
PHAARMASIA LTD.NANANANA21.9
CHEMO PHARMA LABORATORIES LTD.NANANANA21.362.6

Peer Comparison Chart


About ISHITA DRUGS & INDUSTRIES

Ishita Drugs & Industries Ltd., with Security Code 524400, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Ishita Drugs & Industries Adjusts Evaluation Amid Mixed Financial Performance and Challenges

(15 Sep 2025)
Ishita Drugs & Industries has recently adjusted its evaluation score, reflecting a change in technical trends. For Q1 FY25-26,...
Read more →

How volatile is SGHC stock compared to the market - Explosive market performance

(29 Aug 2025)
【Market Discussions】✌️ Join thousands of satisfied investors who have leveraged our insights and market timing to convert modest...
Read more →

Ishita Drugs & Industries Reports Strong Short-Term Gains Amid Long-Term Growth Concerns

(15 Aug 2025)
Ishita Drugs & Industries has recently adjusted its evaluation, highlighting significant improvements in financial performance for the quarter ending June...
Read more →

Ishita Drugs & Industries Reports Strong Financial Growth in June 2025 Results

(13 Aug 2025)
Ishita Drugs & Industries has announced its financial results for the quarter ending June 2025, highlighting significant growth.
Read more →

Ishita Drugs & Industries standalone net profit rises 100.00% in the June 2025 quarter

(13 Aug 2025)
Net profit of Ishita Drugs & Industries rose 100.00% to Rs 0.30 crore in the quarter ended June 2025 as against Rs 0.15 crore during the previous quarter...
Read more →

Olympia Industries standalone net profit rises 37.93% in the June 2025 quarter

(13 Aug 2025)
Net profit of Olympia Industries rose 37.93% to Rs 0.40 crore in the quarter ended June 2025 as against Rs 0.29 crore during the previous quarter ended June...
Read more →